Benzinga | Jun 21, 2021 11:23AM EDT

Masimo's Wearable Thermometer Scores FDA Approval For Prescription, OTC Use

* Masimo (NASDAQ:MASI) has announced that Radius T?, a wearable, wireless thermometer, has received FDA 510(k) clearance for both prescription and over-the-counter (OTC) use on patients and consumers five years and older.

* With continuous temperature measurements and Bluetooth connectivity, Radius T? automates remote, ongoing body temperature status for clinicians through its paired connection to a Masimo patient monitoring or telehealth solution and for consumers through the Masimo Radius T? smartphone application.

* For prescription use, Radius T? is compatible with both the Root Patient Monitoring and Connectivity Hub and the Rad-97 patient monitor for use in the hospital, as part of the Masimo Hospital Automation platform.

* Price Action: MASI shares are down 1.27% at $237 during the market session on the last check Monday.